Cargando…
Acquired thrombotic thrombocytopenic purpura after AstraZeneca vaccine: A case report
BACKGROUND: Rare cases of acquired thrombotic thrombocytopenic purpura (aTTP) have been reported since the administration of the COVID-19 vaccination. Based on our information, the present study provides the first case report of aTTP developed after the COVID-19 vaccination in Iran. CASE PRESENTATIO...
Autores principales: | Yaghoubi, Fatemeh, Dalil, Davood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272963/ https://www.ncbi.nlm.nih.gov/pubmed/35872667 http://dx.doi.org/10.22088/cjim.13.0.299 |
Ejemplares similares
-
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca‐Oxford COVID‐19 vaccine
por: Al‐Ahmad, Mona, et al.
Publicado: (2021) -
Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
Ischemic stroke after AstraZeneca (Covid-19) vaccination
por: Alammar, Muath A.
Publicado: (2021) -
Thrombotic events after AstraZeneca vaccine: What if it was related to dysfunctional immune response?
por: Billy, Eric, et al.
Publicado: (2021) -
Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia
por: Garnier, Matthieu, et al.
Publicado: (2021)